We are live on ! Find out more
IART icon

Integra LifeSciences
IART

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46% → 90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264 → 261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$140M
2
EVM
Eaton Vance Management
Massachusetts
+$75M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$20.8M
5
Morgan Stanley
Morgan Stanley
New York
+$14.4M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$55.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$35.3M
3
CB
Cooke & Bieler
Pennsylvania
-$26.1M
4
Norges Bank
Norges Bank
Norway
-$17.2M
5
Jennison Associates
Jennison Associates
New York
-$12.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
HWMA
201
Heritage Wealth Management (Arizona)
Arizona
$196K +$30.7K +434 +18%
Koshinski Asset Management
202
Koshinski Asset Management
Illinois
$188K +$194K +2,744 New
HNB
203
Huntington National Bank
Ohio
$131K +$8.48K +120 +7%
MAM
204
Meeder Asset Management
Ohio
$108K – – –
FHA
205
First Horizon Advisors
Tennessee
$105K +$495 +7 +0.5%
AssetMark Inc
206
AssetMark Inc
California
$58K – – –
SOW
207
State of Wyoming
Wyoming
$49K -$11.8K -167 -19%
DCM
208
Dupont Capital Management
Delaware
$42K -$5.72K -81 -12%
SWM
209
Spire Wealth Management
Virginia
$39K – – –
LWM
210
Liberty Wealth Management
California
$36K +$18.5K +262 +99%
SPIA
211
Steward Partners Investment Advisory
New York
$28K – – –
JCM
212
Jacobi Capital Management
Pennsylvania
$27K – – –
LSA
213
Leonteq Securities AG
Switzerland
$26.8K +$27.7K +392 New
Fidelity Investments
214
Fidelity Investments
Massachusetts
$26K -$4.6M -65,150 -99%
APA
215
American Portfolios Advisors
New York
$21.5K +$3.39K +48 +18%
CA
216
Clearstead Advisors
Ohio
$21K +$21.2K +300 New
DFCM
217
Dark Forest Capital Management
Puerto Rico
$18K -$44.3K -627 -71%
Fifth Third Bancorp
218
Fifth Third Bancorp
Ohio
$18K +$1.13K +16 +6%
IUHSA
219
Itau Unibanco Holding S.A.
Brazil
$14K +$353 +5 +3%
CT
220
Caldwell Trust
Florida
$13.7K – – –
CAL
221
Capital Analysts LLC
Pennsylvania
$13K – – –
IPW
222
IronBridge Private Wealth
Texas
$13K – – –
QCG
223
Quadrant Capital Group
Ohio
$13K – – –
BCA
224
Berman Capital Advisors
Georgia
$13K +$2.19K +31 +18%
RE
225
RBC Europe
United Kingdom
$12.2K – – –
7 8
9
10 11

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.